Braingaze signs an agreement with an American company to commercialize a digital diagnostic solution for attention deficit hyperactivity disorder
The University of Barcelona (UB) digital cognitive health spin-off, Braingaze, and Tris Pharma, Inc., a commercial-stage biopharmaceutical company focused on...